Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM161B is a member of the FAM161 protein family, which includes centrosomal and centriolar components highly conserved in vertebrates. FAM161B is homologous to FAM161A, a well-studied protein implicated in the structural integrity and scaffolding of centrioles and transition zones in ciliated cells. While FAM161B's specific function is not delineated in humans, by analogy to FAM161A, it likely participates in the organization and stability of the microtubule-based structures within the centriole or centrosome. No disease associations, interacting drugs, or use as a classic therapeutic target are currently reported for FAM161B. Its best-characterized role—by homology and classification—is as a cytoskeletal-associated centrosomal protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 161 member B (FAM161B).